Special vulnerability of children to environmental exposures

J Leith Sly1, David O Carpenter

  • 1University of Queensland, Brisbane, Queensland,Australia. Leith.sly@uq.edu.au

Insights

Children are highly susceptible to environmental toxins during development, leading to lifelong health issues. Protecting their environment is crucial for preventing cognitive, developmental, and disease risks, especially for those in poverty.

Area of Science:

  • Environmental Health
  • Developmental Toxicology
  • Pediatric Health

Background:

  • Fetal and childhood stages are critical developmental periods with heightened vulnerability to environmental exposures.
  • Rapid cell division, organogenesis, and growth during these stages make them susceptible to disruptions with lifelong consequences.
  • Environmental insults can impact cognitive function, behavior, growth, reproductive, and immune systems, increasing later-life disease risks like cancer.

Purpose of the Study:

  • To highlight the critical vulnerability of fetal and childhood development to environmental insults.
  • To underscore the importance of the developmental environment in mitigating long-term health risks.
  • To emphasize the role of poverty as a significant risk factor for environmental exposures and subsequent diseases.

Main Methods:

  • Review of existing literature on environmental exposures during fetal life and childhood.
  • Analysis of pathways through which environmental chemicals and infectious agents impact development.
  • Examination of socioeconomic factors, particularly poverty, influencing exposure risks.

Main Results:

  • Environmental exposures during critical developmental windows can lead to irreversible abnormalities.
  • Disruptions can manifest as altered cognitive function, behavior, growth, and immune/reproductive systems.
  • Poverty exacerbates exposure risks and increases the likelihood of developing chronic diseases later in life.

Conclusions:

  • Protecting the environment during fetal development and childhood is paramount for preventing long-term health deficits.
  • Interventions must address environmental exposures and socioeconomic disparities, especially poverty.
  • Safeguarding children's developmental environment is an investment in the future generation's health.

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...